Abbott Loses Appeal Bid In HIV Drug Litigation
Abbott Laboratories has failed in its bid for an interlocutory appeal to determine whether an appeals court's decision regarding bundled discounts applies to four antitrust suits targeting Abbott's HIV treatments Norvir...To view the full article, register now.
Already a subscriber? Click here to view full article